Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
san diego blog main
6
×
san diego top stories
san francisco blog main
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
cancer
fda
roche
adverum biotechnologies
bristol-myers squibb
drugs
larotrectinib
loxo oncology
lung cancer
merck
sage therapeutics
startups
What
cancer
6
×
drug
6
×
medicine
biotech
fda
medical
new
roundup
advanced
ahead
alzheimer's
ambien
american
annual
approved
arrival
asco
athena
attendees
attention
award
bad
bio
brain
camp’s
case
cash
ceo
chicago
chief
city
clinical
combinations
community’s
countouriotis
data
days
death
decades
deeper
Language
unset
Current search:
drug
×
cancer
×
" san diego blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More